1460 articles
PYPL (Financial Services)

PayPal's new CEO Enrique Lores is reorganizing the company into three standalone segments, separating Venmo for the first time as the company faces takeover interest from potential buyers including Stripe. The restructuring aims to make business units easier to track or potentially sell, as PayPal's stock has fallen roughly 80% from its pandemic peak.

Show details
Must Read Fed Holds Rates; Most Dissent Since 1992
CNBC | 51 days ago

The Federal Reserve held interest rates steady at 3.5%-3.75% but experienced its highest level of dissent since 1992, with a 8-4 vote split. Four members dissented for different reasons amid persistent inflation concerns and uncertainty surrounding Chair Jerome Powell's departure as Kevin Warsh awaits Senate confirmation as the next Fed chair.

Show details
BNO (Unknown) DBO (Unknown) IEO (Unknown) OIH (Unknown) PXJ (Unknown) +3 more

Seven OPEC+ members plan to meet Sunday to agree on an oil output increase for June, but will adjust the hike to exclude the UAE following its surprise exit from the group on Tuesday. Despite the planned quota increase, most members cannot actually boost production due to supply disruptions caused by the effective closure of the Strait of Hormuz amid the U.S.-Israeli conflict with Iran.

Show details
AMZN (Consumer Cyclical)

Amazon is set to report first-quarter earnings after market close on Wednesday, with analysts expecting 14% revenue growth to $177.3 billion. Wall Street will focus on Amazon Web Services growth, projected at 26% year-over-year, and the company's massive AI infrastructure spending plans. The report comes amid supply chain disruptions from the U.S.-Iran conflict and Amazon's deepening investments in AI partnerships with OpenAI and Anthropic.

Show details
F (Consumer Cyclical)

Ford Motor is scheduled to report first-quarter earnings after market close on Wednesday, with analysts expecting adjusted earnings per share and automotive revenue of $38.82 billion. The results would represent a 3.7% increase in automotive revenue and 35.7% increase in adjusted earnings compared to the prior year quarter.

Show details
SPOT (Communication Services) UMGNF (Communication Services) UNVGY (Communication Services)

Universal Music Group announced it will sell half of its equity stake in Spotify, using proceeds primarily for share buybacks, and plans to expand its buyback program by an additional 500 million euros. The world's largest music company reported flat Q1 revenue of 2.9 billion euros in reported terms, though this represented 8.1% growth in constant currency, with results impacted by weak dollar exchange rates.

Show details
POAHY (Consumer Cyclical)

Porsche reported a 22% decline in first-quarter operating profit to 595 million euros, increasing pressure on CEO Michael Leiters to implement cost cuts and boost sales. Despite the significant profit drop, the luxury automaker maintained a 7.1% operating margin, which fell at the upper end of its forecast range.

Show details
UBER (Technology)

Uber announced a major expansion into travel services at its annual Go-Get event in New York, including hotel bookings through Expedia integration, AI-powered voice bookings using OpenAI models, and shopping features. The move positions Uber as an all-in-one super app and puts it in direct competition with travel platforms like Booking and Airbnb as the company continues diversifying beyond ridesharing.

Show details

U.S. crude oil inventories fell by 6.2 million barrels in the week ended April 24, significantly exceeding analyst expectations of a 231,000-barrel draw, according to the EIA. Gasoline and distillate stocks also declined more than anticipated, with drops of 6.1 million and 4.5 million barrels respectively. The larger-than-expected inventory drawdowns pushed oil futures up approximately 5%, with Brent crude reaching $116.85 per barrel.

Show details
P-SPAC (Unknown)

SpaceX's IPO filing reveals that Elon Musk has structured the company so that only he can vote to remove himself as CEO and chairman, through his control of super-voting Class B shares. This arrangement goes beyond typical dual-class structures where boards retain formal authority to remove executives. The company has warned prospective investors that this framework will severely limit their ability to influence corporate decisions.

Show details
EL (Consumer Defensive) PUGBY (Consumer Defensive) PUIGF (Consumer Defensive)

Estee Lauder is considering a takeover bid for Puig's Class B shares at 18-19 euros per share, according to sources. The potential deal, first announced in March, would create the world's largest premium beauty player by combining major brands including Tom Ford, Carolina Herrera, and Clinique. Negotiations continue with financial and governance issues still to be resolved.

Show details

Wall Street opened lower on Wednesday, with the Dow falling 92 points and the S&P 500 down 0.18%, as investors awaited a Federal Reserve policy decision and major earnings reports from Big Tech companies including Amazon, Meta, Microsoft, and Alphabet. The cautious tone was amplified by surging oil prices above $104 per barrel amid escalating Iran tensions and questions about the sustainability of AI investments.

Show details
ABBV (Healthcare)

AbbVie reported better-than-expected first quarter results on April 29, driven by strong sales of immunology drugs Skyrizi and Rinvoq, which are compensating for declining revenue from Humira following its 2023 patent expiration. The company raised its full-year earnings forecast as it successfully navigates the transition away from its former blockbuster drug.

Show details
REGN (Healthcare)

Regeneron Pharmaceuticals exceeded first-quarter profit and revenue estimates on April 29, driven by strong sales of its eczema drug Dupixent and cancer drug Libtayo. The results offset competitive pressures facing its blockbuster eye drug Eylea, which has encountered competition from cheaper alternatives and rival treatments.

Show details
PFE (Healthcare)

Pfizer announced on April 29 that its blood cancer drug Elrexfio met the primary endpoint in a late-stage trial for multiple myeloma patients who received at least one prior treatment. The drug demonstrated clinically meaningful improvement in progression-free survival compared to standard care, potentially expanding its current FDA accelerated approval for more heavily pre-treated patients. Elrexfio generated $304 million in sales in 2025.

Show details
AZN (Healthcare)

AstraZeneca will invest £300 million ($405 million) in the UK, Prime Minister Keir Starmer announced on Wednesday. This marks a reversal after the drugmaker previously pulled back projects in Britain, including plans in Cambridge, citing concerns about the business environment.

Show details
CTSH (Technology)

Cognizant Technology forecast third-quarter revenue below Wall Street expectations due to cautious client IT spending amid macroeconomic uncertainty. The company expects Q3 revenue of $5.45-$5.52 billion versus analyst estimates of $5.56 billion, while also trimming its full-year revenue outlook. The New Jersey-based IT services firm reported first-quarter revenue growth of 5.8% to $5.41 billion, meeting expectations.

Show details
KALV (Healthcare)

Italian pharmaceutical company Chiesi Group will acquire U.S.-listed KalVista Pharmaceuticals for approximately $1.9 billion in an all-cash deal, marking Chiesi's largest acquisition ever. The transaction strengthens Chiesi's rare disease portfolio, particularly with KalVista's oral treatment for hereditary angioedema, and expands its U.S. commercial presence. The deal is expected to close in Q3 2026 pending regulatory approvals.

Show details
ETSY (Consumer Cyclical)

Etsy exceeded first-quarter revenue expectations on April 29, reporting $631 million in marketplace revenue versus the $620.9 million analyst estimate. The online marketplace benefited from increased active buyers and higher spending per purchase, driven by lower-priced goods that appealed to inflation-conscious consumers. The company remains largely insulated from tariff pressures as about 90% of its sellers source supplies domestically.

Show details
NEXI (Healthcare)

Italy's state lender Cassa Depositi e Prestiti (CDP), which owns approximately 19% of payments group Nexi, has stated it has no plans to sell its stake in the company. This position comes as private equity firm CVC Capital is reportedly in early stages of exploring a bid to take Nexi private.

Show details